Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
Top Cited Papers
- 24 October 2006
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (16) , W13-W23
- https://doi.org/10.1097/01.aids.0000247564.73009.bc
Abstract
To estimate the global and regional distribution of HIV-1 subtypes and recombinants in 2004. A study was conducted in which molecular epidemiological data on HIV-1 subtype distribution in individual countries were combined with country-specific estimates of the number of people living with HIV. HIV-1 subtype data were collected for 23 874 HIV-1 samples from 70 countries, which together accounted for 89% of all people living with HIV worldwide in 2004. The proportions of HIV-1 infections due to various subtypes detected in each country were combined with the number of HIV infected people in the respective countries to generate regional and global HIV-1 subtype distribution estimates. Subtype C accounted for 50% of all infections worldwide in 2004. Subtypes A, B, D and G accounted for 12%, 10%, 3% and 6%, respectively. The subtypes F, H, J and K together accounted for 0.94% of infections. The circulating recombinant forms CRF01_AE and CRF02_AG each were responsible for 5% of cases, and CRF03_AB for 0.1%. Other recombinants accounted for the remaining 8% of infections. All recombinant forms taken together were responsible for 18% of infections worldwide. Combining data on HIV-1 subtype distribution in individual countries with country-specific estimates of the number of people living with HIV provided a good method to generate estimates of the global and regional HIV-1 genetic diversity in 2004. The results could serve as an important resource for HIV scientists, public health officials and HIV vaccine developers.Keywords
This publication has 26 references indexed in Scilit:
- Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QTJournal of Clinical Microbiology, 2005
- Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected KenyansAIDS, 2003
- Drug‐Selected Resistance Mutations and Non‐B Subtypes in Antiretroviral‐Naive Adults with Established Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2003
- Genetic diversity of HIV-1 in western KenyaAIDS, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003
- Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmissionJournal of General Virology, 2003
- Evaluation of United States-Licensed Human Immunodeficiency Virus Immunoassays for Detection of Group M Viral VariantsJournal of Clinical Microbiology, 2001
- Protease sequences from HIV-1 group M subtypes A???H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwideAIDS, 2000
- Drug Susceptibility of Subtypes A, B, C, D, and E Human Immunodeficiency Virus Type 1 Primary IsolatesAIDS Research and Human Retroviruses, 1998
- ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROLAnnual Review of Immunology, 1997